Thyroid remnant ablation success and disease outcome in stage III or IV differentiated thyroid carcinoma: recombinant human thyrotropin versus thyroid hormone withdrawal.

Vallejo Casas, Juan A; Mena Bares, Luisa M; Gálvez Moreno, Maria A; Moreno Ortega, Estefanía; Marlowe, Robert J; Maza Muret, Francisco R; Albalá González, María D

Vallejo Casas, Juan A; Mena Bares, Luisa M; Gálvez Moreno, Maria A; Moreno Ortega, Estefanía; Marlowe, Robert J; Maza Muret, Francisco R; Albalá González, María D.

Affiliation

Vallejo Casas JA; Department of Nuclear Medicine, "Reina Sofía" University Hospital, University of Córdoba, Córdoba, Spain - jantonio.vallejo.sspa@juntadeandalucia.es.

Q J Nucl Med Mol Imaging ; 60(2): 163-71, 2016 Jun.

Article in En | MEDLINE | ID: mdl-26563902

Subject(s)

Ablation Techniques/methods; Recombinant Proteins/pharmacology; Thyroid Gland/drug effects; Thyroid Hormones/metabolism; Thyroid Neoplasms/drug therapy; Thyroid Neoplasms/pathology; Thyrotropin/pharmacology; Adult; Aged; Aged, 80 and over; Endpoint Determination; Female; Humans; Length of Stay; Male; Middle Aged; Neoplasm Staging; Recombinant Proteins/therapeutic use; Retrospective Studies; Thyroid Neoplasms/metabolism; Thyrotropin/therapeutic use; Treatment Outcome; Young Adult

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Thyroid Gland / Thyroid Hormones / Recombinant Proteins / Thyroid Neoplasms / Thyrotropin / Ablation Techniques Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Q J Nucl Med Mol Imaging Journal subject: MEDICINA NUCLEAR Year: 2016 Type: Article

Search on Google

XML

PubMed Links